Cargando…
Irisin as a Novel Biomarker of Subclinical Atherosclerosis, Cardiovascular Risk and Severe Disease in Axial Spondyloarthritis
INTRODUCTION: Patients with axial spondyloarthritis (axSpA) have a high disease burden mainly due to the rheumatic disease itself, and also exhibit accelerated atherosclerosis, that leads to a higher incidence of cardiovascular (CV) disease. Accordingly, the identification of biomarkers of CV risk a...
Ejemplares similares
-
Vaspin in atherosclerotic disease and cardiovascular risk in axial spondyloarthritis: a genetic and serological study
por: Rueda-Gotor, Javier, et al.
Publicado: (2021) -
Omentin: a biomarker of cardiovascular risk in individuals with axial spondyloarthritis
por: Genre, Fernanda, et al.
Publicado: (2020) -
Potential relation of cardiovascular risk factors to disease activity
in patients with axial spondyloarthritis
por: Ferraz-Amaro, Iván, et al.
Publicado: (2021) -
Association of circulating calprotectin with lipid profile in axial spondyloarthritis
por: Genre, Fernanda, et al.
Publicado: (2018) -
Angiogenic T Cells: Potential Biomarkers for the Early Diagnosis of Interstitial Lung Disease in Autoimmune Diseases?
por: Pulito-Cueto, Verónica, et al.
Publicado: (2022)